Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer

NCT00749450 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

6088

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: capecitabine
DRUG: fluorouracil
DRUG: oxaliplatin

Sponsor

Cancer Research UK, Glasgow